Laboratory Freezers Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Freezers, Refrigerator, Cryopreservation), By End User (Blood Banks, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Medical Laboratories, Hospitals, Pharmacies), By Region, & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 6.21 Billion
CAGR (2026-2031)	4.91%
Fastest Growing Segment	Freezers
Largest Market	North America
Market Size (2031)	USD 8.28 Billion

Market Overview

The Global Laboratory Freezers Market will grow from USD 6.21 Billion in 2025 to USD 8.28 Billion by 2031 at a 4.91% CAGR. Laboratory freezers are specialized refrigeration units designed to store temperature-sensitive biological samples, chemicals, and pharmaceutical products at precise sub-zero temperatures to ensure long-term stability. The market's growth is fundamentally driven by the expansion of global biobanking infrastructure and increased R&D expenditure in the biopharmaceutical sector, which directly escalates the volume of specimens requiring preservation. According to the European Biobanking and BioMolecular resources Research Infrastructure (BBMRI-ERIC), in its 2024 Annual Report, the consortium's network connected approximately 500 biobanks across 32 countries, underscoring the extensive scale of research facilities that necessitate dependable cold storage solutions.

A significant challenge that could impede market expansion is the intense energy consumption associated with ultra-low temperature units, which imposes high operational costs and environmental compliance burdens on facilities. As sustainability regulations tighten globally, the pressure to mitigate the carbon footprint of cold chain equipment has become a critical operational constraint. According to the International Institute for Sustainable Laboratories, in 2024, the International Laboratory Freezer Challenge reported that participating laboratories collectively saved over 31.8 million kWh of energy, a figure that illustrates the immense power requirements and efficiency struggles inherent to this equipment sector.

Key Market Drivers

Increasing Pharmaceutical and Biotechnology R&D Expenditure is a primary engine propelling the Global Laboratory Freezers Market. As biopharmaceutical companies intensify their search for novel therapeutics, particularly in oncology and immunology, the volume of biological samples requiring strict temperature control has surged. This escalation in research activity necessitates an expanded capacity for reliable ultra-low temperature storage to preserve high-value assets such as cell lines and reagents. The financial commitment to this innovation is evident in recent corporate spending; according to Fierce Biotech, in March 2025, Johnson & Johnson reported an increase in its research and development budget of more than $2 billion in 2024 compared to the previous year, highlighting the massive capital fueling the sector's infrastructure needs. This rising investment directly correlates with the procurement of advanced cold storage units to safeguard the integrity of developing therapies.

Advancements in Energy-Efficient and Sustainable Freezer Technology are reshaping market procurement strategies as laboratories strive to reduce operational costs and meet environmental mandates. With traditional ultra-low temperature freezers being significant energy consumers, manufacturers are aggressively integrating hydrocarbon refrigerants and variable-speed compressors to enhance performance while lowering electricity usage. These technological improvements are incentivized by stringent regulatory standards and voluntary certifications. According to the United States Environmental Protection Agency, in October 2024, the newly finalized Energy Star Version 2.0 specification established that certified laboratory grade refrigerators and freezers utilize 37% less energy than standard models. This efficiency drive is critical given the industry's environmental footprint; according to My Green Lab, in November 2024, the global biotech and pharmaceutical sector generated a combined total of 397 million metric tons of carbon dioxide equivalent emissions in 2023, creating an urgent imperative for facilities to upgrade to greener cold storage solutions.

Download Free Sample Report

Key Market Challenges

The intense energy consumption associated with ultra-low temperature units represents a formidable barrier to the Global Laboratory Freezers Market. These refrigeration systems must operate continuously to maintain critical sub-zero environments, resulting in disproportionately high electricity usage that significantly inflates operational budgets for research facilities. This financial burden is particularly acute for institutions managing extensive biobanks, where the cumulative cost of running multiple high-performance units can restrict the capital available for fleet expansion or modernization, effectively limiting market volume.

Concurrently, the escalating pressure to adhere to rigorous environmental sustainability mandates is impeding procurement cycles. Laboratories are continuously scrutinized for their carbon footprint, forcing a reevaluation of energy-intensive equipment acquisitions to align with corporate net-zero targets. According to My Green Lab, in its 2024 Carbon Impact of Biotech & Pharma Report, the publicly listed and private companies within the sector were responsible for a combined total of 397 million metric tons of carbon dioxide equivalent emissions. This massive environmental impact compels organizations to exercise extreme caution before adding power-hungry freezers to their inventory, thereby stalling market momentum as facilities struggle to balance storage needs with emission caps.

Key Market Trends

The Integration of IoT-Enabled Remote Monitoring Systems is fundamentally transforming equipment oversight by replacing traditional localized alarms with cloud-based intelligence. Modern laboratories are increasingly deploying interconnected platforms that provide real-time visibility into temperature stability and door status, thereby mitigating the risk of catastrophic sample loss through predictive analytics. This connectivity allows facility managers to centralize data from multiple units, streamlining compliance with audit trails and ensuring rapid response to thermal excursions. According to Thermo Fisher Scientific, September 2024, in the 'Thermo Fisher Scientific Unveils New Lab Connectivity Solution' announcement, the company introduced the Connect Edge hardware which enables the simultaneous remote monitoring of up to 10 laboratory devices from a single gateway, facilitating scalable fleet management for data-intensive research environments.

Concurrently, the Rising Utilization of Automated Sample Management Solutions is reshaping biobanking workflows to accommodate the exponential growth of biological inventories. As biorepositories expand, the manual retrieval of specimens becomes a bottleneck that introduces temperature variability and human error, prompting a shift toward robotic storage systems that ensure precise cold chain maintenance during handling. These automated archives maximize storage density and retrieval speed, which is essential for population-scale studies. According to Hamilton Storage, May 2024, in the 'Hamilton BiOS Automated Storage Systems to Strengthen UK Biobank's Efforts' press release, the manufacturer confirmed the installation of four high-capacity robotic units at the UK Biobank designed to store more than 12 million biological samples, illustrating the critical role of automation in supporting massive research infrastructure.

Segmental Insights

The Freezers segment is currently witnessing the most rapid growth within the Global Laboratory Freezers Market, driven by an escalating necessity for the long-term preservation of biological specimens. Bio-banks and genomic research centers are increasingly investing in these units to store sensitive samples, such as plasma and tissue, at stable sub-zero temperatures. Furthermore, the rising prominence of mRNA-based therapies has created a critical need for storage solutions that strictly adhere to low-temperature guidelines established by regulatory bodies such as the U.S. Food and Drug Administration. Consequently, healthcare facilities are prioritizing high-performance freezing equipment to ensure sample integrity and regulatory compliance.

Regional Insights

North America holds the leading position in the Global Laboratory Freezers Market, driven by a well-established healthcare infrastructure and a high concentration of pharmaceutical and biotechnology companies. The region benefits from substantial investment in life sciences research, particularly in drug discovery and genomic studies, which necessitates reliable cold storage for biological samples. Furthermore, strict compliance standards established by the U.S. Food and Drug Administration regarding the preservation of blood, vaccines, and temperature-sensitive products enforce the adoption of high-quality freezing equipment. The continuous expansion of biobanking facilities across the United States and Canada further sustains regional market demand.

Recent Developments

• In January 2025, Stirling Ultracold announced the commercial release of the VAULT100, an upright ultra-low temperature freezer with a temperature range of -100°C to -20°C. This new model featured a robust free-piston Stirling engine and improved cabinet design, delivering enhanced temperature uniformity and steady-state adherence to setpoints. The unit included a large touchscreen interface with onboard predictive analytics for freezer diagnostics. The wider temperature range offered laboratories greater flexibility in storage options while maintaining energy efficiency and a small operational footprint, addressing the critical needs of biopharma and academic research.
• In June 2024, Haier Biomedical was officially approved as a supplier on the NHS Supply Chain Pathology Framework in the United Kingdom for the period spanning 2024 to 2028. This inclusion allowed the company to supply a comprehensive range of laboratory equipment, including ultra-low temperature freezers and blood refrigerators, to healthcare providers across the region. The framework aimed to ensure that NHS facilities had access to high-quality and reliable pathology equipment. This development underscored the company's commitment to delivering precise and safe cold storage solutions to the medical sector.
• In April 2024, Thermo Fisher Scientific introduced the TSX Universal Series of ultra-low temperature (ULT) freezers, designed to support various laboratory workflows. The new series features Universal V-Drive technology, which offers tighter temperature control and faster recovery times compared to previous models. These units were designed with sustainability in mind, providing up to 33% energy savings and achieving ENERGY STAR certification. The freezers are suitable for diverse settings, including academic laboratories and Good Manufacturing Practice (GMP) facilities, allowing users to maintain consistent performance across different storage requirements while supporting sustainability initiatives.
• In February 2024, PHC Corporation of North America launched the MDF-DU703VHA-PA, a new model in its VIP ECO SMART ultra-low temperature freezer series. This unit was the first under the PHCbi brand to feature dual voltage capability, enabling laboratories to switch between 115V and 220V power sources. The freezer incorporated inverter compressor technology and natural refrigerants to minimize energy consumption while maintaining secure sample preservation. The launch aimed to provide flexible and energy-efficient cold storage solutions for medical institutions, universities, and pharmaceutical companies requiring reliable specimen protection.

Key Market Players

• ARCTIKO Ltd
• Avantor, Inc.
• BioLife Solutions Inc.
• Blue Star Limited
• Changhong Meiling Co. Ltd
• Evermed s.r.l
• Felix Storch, Inc.
• Haier Biomedical
• Helmer Scientific Inc.
• The Middleby Corporation.

By Product	By End User	By Region
Freezers Refrigerator Cryopreservation	Blood Banks Pharmaceutical & Biotechnology Companies Academic & Research Institutes Medical Laboratories Hospitals Pharmacies	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Laboratory Freezers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Laboratory Freezers Market, By Product:

• Freezers
• Refrigerator
• Cryopreservation

• Laboratory Freezers Market, By End User:

• Blood Banks
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Medical Laboratories
• Hospitals
• Pharmacies

• Laboratory Freezers Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE